Currently out of the existing stock ratings of Shaunak Deepak, 10 are a BUY (100%).

Shaunak Deepak

Work Performance Price Targets & Ratings Chart

Analyst Shaunak Deepak, Previously, Shaunak Deepak worked at JEFFERIES.

Shaunak Deepak’s has documented 16 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on KPTI, Karyopharm Therapeutics at 16-Mar-2017.

Wall Street Analyst Shaunak Deepak

Analyst best performing recommendations are on MNKD (MANNKIND CORP).
MNKD MannKind Corp KPTI Karyopharm Therapeutics RIGL Rigel Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$11

$6.12 (125.41%)

$11

28 days ago
(17-Sep-2025)

2/7 (28.57%)

$5.39 (96.08%)

848

Buy

$15

$10.12 (207.38%)

$10

1 months 11 days ago
(04-Sep-2025)

0/2 (0%)

$9.46 (170.76%)

Buy

$10

$5.12 (104.92%)

$9

1 months 13 days ago
(02-Sep-2025)

0/2 (0%)

$4.49 (81.49%)

Buy

$8

$3.12 (63.93%)

$7

1 months 20 days ago
(25-Aug-2025)

0/3 (0%)

$3.93 (96.56%)

Buy

$12

$7.12 (145.90%)

$6.5

1 years 1 months 18 days ago
(27-Aug-2024)

2/3 (66.67%)

$6.1 (103.39%)

384

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Shaunak Deepak?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?